PharmaEssentia (6446)

Currency in TWD
510.00
+3.00(+0.59%)
Closed·
6446 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 3 days
6446 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
510.00517.00
52 wk Range
440.00796.00
Key Statistics
Bid/Ask
91.40 / 91.50
Prev. Close
565
Open
512
Day's Range
510-517
52 wk Range
440-796
Volume
805.73K
Average Volume (3m)
1.93M
1-Year Change
-22.84%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6446 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
690.50
Upside
+35.39%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

PharmaEssentia News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

PharmaEssentia Company Profile

PharmaEssentia Corporation, a biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally. Its products include Ropeginterferon alfa-2b that is used for the treatment of chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. The company also develops TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint abs for the treatment of solid tumors; P1101 + anti PD-1 for the treatment of hepatocellular carcinoma; and PEG-GCSF for the treatment of neutropenia. In addition, it focuses on the drug research and development programs in the areas of hematology, infectious disease, and oncology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.

Employees
131
Market
Taiwan

Compare 6446 to Peers and Sector

Metrics to compare
6446
Peers
Sector
Relationship
P/E Ratio
43.3x−24.7x−0.5x
PEG Ratio
0.060.020.00
Price/Book
5.8x2.8x2.6x
Price / LTM Sales
14.9x30.5x3.3x
Upside (Analyst Target)
32.8%0.0%43.5%
Fair Value Upside
Unlock−12.6%6.8%Unlock

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 690.50
(+35.39% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 11.76%
Dividend Yield
-
Industry Median 0.97%
Annualised payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 11, 2025
EPS / Forecast
3.78 / 3.21
Revenue / Forecast
3.26B / 3.28B
EPS Revisions
Last 90 days

6446 Income Statement

FAQ

What Stock Exchange Does PharmaEssentia Trade On?

PharmaEssentia is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for PharmaEssentia?

The stock symbol for PharmaEssentia is "6446."

What Is the PharmaEssentia Market Cap?

As of today, PharmaEssentia market cap is 169.97B.

What Is PharmaEssentia's Earnings Per Share (TTM)?

The PharmaEssentia EPS (TTM) is 11.76.

When Is the Next PharmaEssentia Earnings Date?

PharmaEssentia will release its next earnings report on 11 Aug 2025.

From a Technical Analysis Perspective, Is 6446 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has PharmaEssentia Stock Split?

PharmaEssentia has split 2 times.

How Many Employees Does PharmaEssentia Have?

PharmaEssentia has 131 employees.

What is the current trading status of PharmaEssentia (6446)?

As of 09 Aug 2025, PharmaEssentia (6446) is trading at a price of 510.00, with a previous close of 565.00. The stock has fluctuated within a day range of 510.00 to 517.00, while its 52-week range spans from 440.00 to 796.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.